Works matching IS 25233548 AND DT 2022 AND VI 42 AND IP 11
Results: 12
Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities.
- Published in:
- Cancer Communications, 2022, v. 42, n. 11, p. 1049, doi. 10.1002/cac2.12374
- By:
- Publication type:
- Article
SDCBP‐AS1 destabilizes β‐catenin by regulating ubiquitination and SUMOylation of hnRNP K to suppress gastric tumorigenicity and metastasis.
- Published in:
- Cancer Communications, 2022, v. 42, n. 11, p. 1141, doi. 10.1002/cac2.12367
- By:
- Publication type:
- Article
Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity.
- Published in:
- Cancer Communications, 2022, v. 42, n. 11, p. 1212, doi. 10.1002/cac2.12365
- By:
- Publication type:
- Article
Activation of Piezo1 contributes to matrix stiffness‐induced angiogenesis in hepatocellular carcinoma.
- Published in:
- Cancer Communications, 2022, v. 42, n. 11, p. 1162, doi. 10.1002/cac2.12364
- By:
- Publication type:
- Article
A novel histone deacetylase inhibitor exerts promising anti‐breast cancer activity via triggering AIFM1‐dependent programmed necrosis.
- Published in:
- Cancer Communications, 2022, v. 42, n. 11, p. 1207, doi. 10.1002/cac2.12362
- By:
- Publication type:
- Article
An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment.
- Published in:
- Cancer Communications, 2022, v. 42, n. 11, p. 1083, doi. 10.1002/cac2.12361
- By:
- Publication type:
- Article
AIMP1 promotes multiple myeloma malignancy through interacting with ANP32A to mediate histone H3 acetylation.
- Published in:
- Cancer Communications, 2022, v. 42, n. 11, p. 1185, doi. 10.1002/cac2.12356
- By:
- Publication type:
- Article
Peripheral naïve CD8<sup>+</sup> T cells as a predictive biomarker of response to lenvatinib plus an anti‐PD‐1 antibody in advanced hepatocellular carcinoma: a biomarker study.
- Published in:
- Cancer Communications, 2022, v. 42, n. 11, p. 1226, doi. 10.1002/cac2.12350
- By:
- Publication type:
- Article
A serum microRNA signature for enhanced selection of people for lung cancer screening.
- Published in:
- Cancer Communications, 2022, v. 42, n. 11, p. 1222, doi. 10.1002/cac2.12346
- By:
- Publication type:
- Article
Tumor‐associated macrophages in liver cancer: From mechanisms to therapy.
- Published in:
- Cancer Communications, 2022, v. 42, n. 11, p. 1112, doi. 10.1002/cac2.12345
- By:
- Publication type:
- Article
Diagnostic value of genetic mutation analysis and mutation profiling of cell‐free DNA in intraocular fluid for vitreoretinal lymphoma.
- Published in:
- Cancer Communications, 2022, v. 42, n. 11, p. 1217, doi. 10.1002/cac2.12344
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer Communications, 2022, v. 42, n. 11, p. 1047, doi. 10.1002/cac2.12175
- Publication type:
- Article